This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Upper Central Incisor Edentulism
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

Horizontal bone augmentation procedures are commonly used to increase bone width to allow the placement of dental implants or to improve aesthetics in deficient areas. Smaller diameter implants could be used instead in order to avoid bone augmentation procedures. The comparison between these two solutions will be evaluated in the trial.

Provided treatments

  • Device: ICE dental implant 4.2 mm
  • Device: NICE dental implant 3.2 mm
  • Device: Alpha Bio's Graft Bovine bone
  • Device: Alpha Bio's Graft resorbable membrane

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02897193. The sponsor of the trial is Alpha - Bio Tec Ltd. and it is looking for 42 volunteers for the current phase.
Official trial title:
3.2 mm Diameter Implants and Soft Tissue Grafts in Alternative to Horizontal Bone Augmentation for Placing 4.2 mm Diameter Implants at Central Incisors. A Multicenter Randomised Controlled Trial